Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
ELI LILLY & Co (LLY)
LILLY ENDOWMENT INC — 10% Owner
Shares
1,224
Price
$1,091.05
Total Value
$1.34M
Shares Held After
92,173,748
% of Holdings
0.0%
ELI LILLY & Co (LLY)
LILLY ENDOWMENT INC — 10% Owner
Shares
3,575
Price
$1,090.18
Total Value
$3.90M
Shares Held After
92,174,972
% of Holdings
0.0%
ELI LILLY & Co (LLY)
LILLY ENDOWMENT INC — 10% Owner
Shares
930
Price
$1,088.97
Total Value
$1.01M
Shares Held After
92,178,547
% of Holdings
0.0%
ELI LILLY & Co (LLY)
LILLY ENDOWMENT INC — 10% Owner
Shares
1,070
Price
$1,087.80
Total Value
$1.16M
Shares Held After
92,179,477
% of Holdings
0.0%
ELI LILLY & Co (LLY)
LILLY ENDOWMENT INC — 10% Owner
Shares
7,684
Price
$1,086.75
Total Value
$8.35M
Shares Held After
92,180,547
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
Bassler Bonnie L — Director
Shares
1,500
Price
$800.00
Total Value
$1.20M
Shares Held After
1,703
% of Holdings
46.8%
INCYTE CORP (INCY)
Issa Mohamed Khairie — EVP, Head of US Oncology
Shares
10,856
Price
$109.07
Total Value
$1.18M
Shares Held After
66,132
% of Holdings
14.1%
AnaptysBio, Inc. (ANAB)
MULROY DENNIS — CHIEF FINANCIAL OFFICER
Shares
1,908
Price
$45.11
Total Value
$86.07K
Shares Held After
17,667
% of Holdings
9.7%
AnaptysBio, Inc. (ANAB)
Faga Daniel — Director
Shares
9,202
Price
$45.11
Total Value
$415.10K
Shares Held After
466,787
% of Holdings
1.9%
AnaptysBio, Inc. (ANAB)
Lizzul Paul F. — Chief Medical Officer
Shares
2,235
Price
$45.11
Total Value
$100.82K
Shares Held After
37,213
% of Holdings
5.7%
AnaptysBio, Inc. (ANAB)
LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Shares
500
Price
$47.23
Total Value
$23.61K
Shares Held After
9,157
% of Holdings
5.2%
AnaptysBio, Inc. (ANAB)
LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Shares
1,841
Price
$46.13
Total Value
$84.93K
Shares Held After
9,657
% of Holdings
16.0%
AnaptysBio, Inc. (ANAB)
LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Shares
5,281
Price
$45.38
Total Value
$239.67K
Shares Held After
11,498
% of Holdings
31.5%
AnaptysBio, Inc. (ANAB)
LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Shares
2,017
Price
$45.11
Total Value
$90.99K
Shares Held After
16,779
% of Holdings
10.7%
Maze Therapeutics, Inc. (MAZE)
Sohn Catherine A. — Director
Shares
26,920
Price
$39.11
Total Value
$1.05M
Shares Held After
0
% of Holdings
100.0%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
709
Price
$175.07
Total Value
$124.12K
Shares Held After
58,090
% of Holdings
1.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
52
Price
$77.48
Total Value
$4.03K
Shares Held After
6,850
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
1,026
Price
$77.48
Total Value
$79.49K
Shares Held After
116,077
% of Holdings
0.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
11
Price
$78.98
Total Value
$868.78
Shares Held After
117,659
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
269
Price
$77.92
Total Value
$20.96K
Shares Held After
117,670
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
471
Price
$77.10
Total Value
$36.31K
Shares Held After
117,939
% of Holdings
0.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
38
Price
$78.60
Total Value
$2.99K
Shares Held After
117,659
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
949
Price
$77.91
Total Value
$73.94K
Shares Held After
117,697
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,638
Price
$77.11
Total Value
$126.31K
Shares Held After
118,646
% of Holdings
1.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,503
Price
$77.48
Total Value
$116.45K
Shares Held After
117,659
% of Holdings
1.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,357
Price
$175.07
Total Value
$412.64K
Shares Held After
318,630
% of Holdings
0.7%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
642
Price
$77.48
Total Value
$49.74K
Shares Held After
93,294
% of Holdings
0.7%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
3,016
Price
$77.48
Total Value
$233.68K
Shares Held After
396,967
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
1,352
Price
$77.48
Total Value
$104.75K
Shares Held After
87,489
% of Holdings
1.5%
PTC THERAPEUTICS, INC. (PTCT)
Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Shares
1,235
Price
$77.45
Total Value
$95.65K
Shares Held After
73,727
% of Holdings
1.6%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
1,434
Price
$175.84
Total Value
$252.15K
Shares Held After
91,705
% of Holdings
1.5%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
1,678
Price
$175.07
Total Value
$293.77K
Shares Held After
81,953
% of Holdings
2.0%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
802
Price
$175.07
Total Value
$140.41K
Shares Held After
109,660
% of Holdings
0.7%
Movano Inc. (MOVE)
Leabman Michael Aaron — Director
Shares
3,293
Price
$7.34
Total Value
$24.17K
Shares Held After
39,313
% of Holdings
7.7%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
50,000
Price
$16.38
Total Value
$819.00K
Shares Held After
316,155
% of Holdings
15.8%
Warby Parker Inc. (WRBY)
Gilboa David Abraham — Director
Shares
75,000
Price
$27.09
Total Value
$2.03M
Shares Held After
37,247
% of Holdings
66.8%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
50,000
Price
$27.08
Total Value
$1.35M
Shares Held After
37,119
% of Holdings
57.4%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
100
Price
$80.06
Total Value
$8.01K
Shares Held After
212,523
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
826
Price
$79.04
Total Value
$65.29K
Shares Held After
212,623
% of Holdings
0.4%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
14,820
Price
$77.90
Total Value
$1.15M
Shares Held After
213,449
% of Holdings
6.5%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,954
Price
$77.13
Total Value
$227.84K
Shares Held After
228,269
% of Holdings
1.3%
Keenova Therapeutics plc (MNK)
Silver Point Capital L.P. — 10% Owner
Shares
250,000
Price
$92.25
Total Value
$23.06M
Shares Held After
4,952,714
% of Holdings
5.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
664
Price
$331.76
Total Value
$220.29K
Shares Held After
0
% of Holdings
100.0%
Avidity Biosciences, Inc. (RNAM)
Boyce Sarah — Director
Shares
8,576
Price
$72.23
Total Value
$619.44K
Shares Held After
283,394
% of Holdings
2.9%
Avidity Biosciences, Inc. (RNAM)
Calderaro Charles III — Chief Technical Officer
Shares
3,727
Price
$72.23
Total Value
$269.20K
Shares Held After
49,797
% of Holdings
7.0%
Avidity Biosciences, Inc. (RNAM)
McCarthy Teresa — Chief Human Resources Officer
Shares
1,965
Price
$72.23
Total Value
$141.93K
Shares Held After
116,867
% of Holdings
1.7%
Avidity Biosciences, Inc. (RNAM)
Moriarty John B — Chief Legal Officer
Shares
2,374
Price
$72.23
Total Value
$171.47K
Shares Held After
74,557
% of Holdings
3.1%
Avidity Biosciences, Inc. (RNAM)
MacLean Michael F — Chief Financial Officer
Shares
1,974
Price
$72.23
Total Value
$142.58K
Shares Held After
63,832
% of Holdings
3.0%
Avidity Biosciences, Inc. (RNAM)
Hughes Steven George — Chief Medical Officer
Shares
2,373
Price
$72.23
Total Value
$171.40K
Shares Held After
36,494
% of Holdings
6.1%
Avidity Biosciences, Inc. (RNAM)
Flanagan W. Michael — Chief Scientific Officer
Shares
2,373
Price
$72.23
Total Value
$171.40K
Shares Held After
91,627
% of Holdings
2.5%
Showing 1051–1100 of 1606 transactions (page 22 of 33)